Upscale AI | $5,500,000 | (May 13, 2025)
Zendo | $2,310,525 | (May 13, 2025)
theom | $20,000,000 | (May 13, 2025)
Certified by Founder
Lodge
Ensoma
start up
United States
- Boston, MA
- 06/02/2023
- Series B
- $85,000,000
At Ensoma, we develop one-time in vivo treatments that precisely engineer any or all blood and immune cells to cure diseases from within.
- Industry Biotechnology Research
- Website https://ensoma.com/
- LinkedIn https://www.linkedin.com/company/ensomabio/people/?keywords=founder
GLASS Imaging | $20,000,000 | (May 13, 2025)
Tobin Scientific | $65,000,000 | (May 13, 2025)
Axe | $1,666,102 | (May 13, 2025)
Zapia AI | $7,250,000 | (May 13, 2025)
TensorStax | $5,000,000 | (May 13, 2025)
Alt DRX | $2,700,000 | (May 13, 2025)
Miden | $25,000,000 | (May 13, 2025)
InBrain Pharma | $2,000,943 | (May 13, 2025)
Zebu Intelligent Systems Pvt Ltd | $1,000,000 | (May 9, 2025)